MedPath

buprenorphine efficacy in methamphetamin dependency

Phase 3
Recruiting
Conditions
Methamphetamine use disorder.
Mental and behavioral disorders due to use of other stimulants, including caffeine
F10-F19
Registration Number
IRCT20090801002266N12
Lead Sponsor
Esfarayen University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

1) People 18-60 years old 2)Having the DSM-V criteria for methamphetamine use disorder 3) It is dependent only on methamphetamine 4) No pregnancy and lactation

Exclusion Criteria

1)Any psychiatric disorder that require hospitalization 2) Medical condition that interfere with participating in the study 3)Any side effect that interfere with continuation of buprenorphin

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Substance use craving. Timepoint: weeks 1-8 and 12,16,20,and 24. Method of measurement: questionair.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath